M
Maat Pharma SA
PAR:MAAT
Maat Pharma SA
PAR:MAAT
Price:
6.98
EUR
1.45%
Market Cap:
€131.4m
Income Statement
Earnings Waterfall
Maat Pharma SA
Maat Pharma SA
Income Statement
Maat Pharma SA
Maat Pharma SA
Currency: EUR
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Revenue |
1
N/A
|
1
+11%
|
1
+32%
|
2
+62%
|
2
-4%
|
3
+15%
|
3
+25%
|
4
+22%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
| Gross Profit |
1
N/A
|
1
+5%
|
1
+29%
|
2
+62%
|
2
-6%
|
2
+5%
|
2
+13%
|
2
+23%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(10)
|
(13)
|
(15)
|
(16)
|
(22)
|
(25)
|
(30)
|
(33)
|
|
| Selling, General & Administrative |
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
|
| Research & Development |
(9)
|
(12)
|
(14)
|
(17)
|
(21)
|
(24)
|
(27)
|
(29)
|
|
| Other Operating Expenses |
2
|
3
|
4
|
5
|
5
|
4
|
4
|
4
|
|
| Operating Income |
(9)
N/A
|
(12)
-38%
|
(14)
-10%
|
(15)
-9%
|
(20)
-35%
|
(24)
-22%
|
(28)
-16%
|
(31)
-8%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
0
|
0
|
|
| Pre-Tax Income |
(9)
N/A
|
(12)
-37%
|
(14)
-11%
|
(15)
-7%
|
(20)
-34%
|
(24)
-23%
|
(29)
-19%
|
(31)
-8%
|
|
| Net Income | |||||||||
| Income from Continuing Operations |
(9)
|
(12)
|
(14)
|
(15)
|
(20)
|
(24)
|
(29)
|
(31)
|
|
| Net Income (Common) |
(9)
N/A
|
(12)
-37%
|
(14)
-11%
|
(15)
-7%
|
(20)
-34%
|
(24)
-23%
|
(29)
-19%
|
(31)
-8%
|
|
| EPS (Diluted) |
-0.91
N/A
|
-1.24
-36%
|
-1.39
-12%
|
-1.32
+5%
|
-1.73
-31%
|
-2.02
-17%
|
-2.21
-9%
|
-2.05
+7%
|
|
Switch to:
Switch to:
See Also
Discover More
